Repatha 140 MG in 1 ML Auto-Injector
- RxCUI
- 1665900
- RxNorm name
- Repatha 140 MG in 1 ML Auto-Injector
- Display name
- Repatha 140 MG in 1 ML Auto-Injector
- Full name
- Repatha 140 MG in 1 ML Auto-Injector
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:21
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125522 | Repatha | evolocumab | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| REPATHA | EVOLOCUMAB | Amgen USA Inc. | cd61e902-166d-4aa6-9f3c-a18c1008d07e | 2026-07-16 | Warnings, Adverse reactions | 1665900 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| cd61e902-166d-4aa6-9f3c-a18c1008d07e | Repatha 140 MG in 1 ML Auto-Injector | PSN | 27 | These highlights do not include all the information needed to use REPATHA ® safely and effectively. See full prescribing information for REPATHA. REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 2015 | 20260122 |
| cd61e902-166d-4aa6-9f3c-a18c1008d07e | 1 ML Repatha SureClick 140 MG/ML Auto-Injector | SY | 27 | These highlights do not include all the information needed to use REPATHA ® safely and effectively. See full prescribing information for REPATHA. REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 2015 | 20260122 |
| cd61e902-166d-4aa6-9f3c-a18c1008d07e | 1 ML Repatha 140 MG/ML Auto-Injector | SY | 27 | These highlights do not include all the information needed to use REPATHA ® safely and effectively. See full prescribing information for REPATHA. REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 2015 | 20260122 |
| cd61e902-166d-4aa6-9f3c-a18c1008d07e | 1 ML evolocumab 140 MG/ML Auto-Injector [Repatha] | SBD | 27 | These highlights do not include all the information needed to use REPATHA ® safely and effectively. See full prescribing information for REPATHA. REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 2015 | 20260122 |